Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for Tenders 2009 > News item |
Nabi Biopharmaceuticals buys $10.4 million in 2.875% convertible notes for $10.1 million
By Devika Patel
Knoxville, Tenn., May 6 - Nabi Biopharmaceuticals said it bought back $10.4 million of its 2.875% convertible senior notes for $10.1 million in the first quarter.
There are $6 million of the convertibles remaining.
Nabi is a Boca Raton, Fla.-based biotech firm.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.